Clinical Trial Update: Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers ASC-101 in patients with hematologic malignancies undergoing dual-cord umbilical cord blood transplantation (Phase 1/Phase 2).…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Lymphoma
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• ASC-101

Snippet

Sponsor: Targazyme, Inc. | Conditions: Blood And Marrow Transplantation, Leukemia | Phase 1, Phase 2 | Status: UNKNOWN